The Macroprolactin Test is a specialized diagnostic assessment conducted to measure the level of macroprolactin in the blood. Macroprolactin is a larger molecular form of the prolactin hormone, which, when elevated, can lead to various health issues including infertility, menstrual irregularities, and galactorrhea (unintended milk production). Unlike the standard prolactin test, this test specifically identifies the presence and quantity of macroprolactin, providing a clearer understanding of certain endocrine disorders.
This test is particularly important for patients who have symptoms of high prolactin levels but normal prolactin test results, as it helps in distinguishing between the active and less active forms of prolactin in the body. The process involves a simple blood draw, and the sample is then analyzed for macroprolactin content.
In the UAE, the Macroprolactin Test is available at DNA Labs, a leading laboratory known for its state-of-the-art facilities and accurate diagnostic services. The cost of the test at DNA Labs UAE is 3600 AED, reflecting the specialized nature of the assessment and the sophisticated technology employed in the analysis. Patients seeking this test can expect professional service and reliable results, contributing to better-informed healthcare decisions.
The Pan Fungal Detection and Identification PCR Test, available at DNA Labs UAE for a cost of 3670 AED, is a sophisticated diagnostic tool designed to accurately detect and identify a wide array of fungal pathogens from clinical samples. Utilizing the Polymerase Chain Reaction (PCR) technique, this test amplifies small segments of DNA to a size that can be observed and analyzed, enabling the identification of fungal species that are often difficult to diagnose through traditional methods.
This test is particularly crucial in clinical settings where rapid and precise identification of fungal infections is necessary to guide effective treatment decisions. Given the broad range of fungi that can cause infections in humans, the Pan Fungal Detection and Identification PCR Test offers a comprehensive approach, enhancing the ability of healthcare providers to diagnose invasive fungal infections promptly and accurately.
By choosing DNA Labs UAE for this test, patients and healthcare providers benefit from the lab's state-of-the-art facilities and experienced professionals, ensuring reliable results. The test's cost of 3670 AED reflects the advanced technology and expertise required to perform such sophisticated diagnostic procedures.
The "Hepatitis B Virus Genotyping Drug Resistance and Quantitative PCR Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to provide comprehensive insights into the Hepatitis B Virus (HBV) infection. Priced at 3650 AED, this test serves multiple purposes. Firstly, it identifies the genotype of the HBV, which is crucial for tailoring the most effective treatment plan, as different genotypes can respond differently to medications. Secondly, it assesses the virus for any mutations that might confer resistance to antiviral drugs, ensuring that the chosen treatment regimen remains effective. Lastly, through quantitative PCR (Polymerase Chain Reaction), the test measures the viral load in the blood, offering vital information on the severity of the infection and guiding treatment decisions. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test is a key resource for healthcare providers managing patients with HBV, enabling personalized and precise treatment strategies.
The Interferon-Beta (IFN-β) IgG MAID (Myxovirus Resistance Protein A Induction Deficiency) Test is a specialized diagnostic assay used to assess the presence and activity of neutralizing antibodies against interferon-beta in patients undergoing interferon-beta therapy. Interferon-beta is a common treatment for multiple sclerosis (MS) and certain other conditions, but over time, some patients may develop antibodies that neutralize the medication's effects, leading to a decrease in treatment efficacy.
The test works by measuring the ability of the patient's antibodies to interfere with the pathway interferon-beta uses to exert its effect, specifically looking at the induction of the Myxovirus Resistance Protein A (MxA) – a protein that is highly induced by interferon-beta and serves as a marker for its activity. By assessing the presence of these neutralizing antibodies, healthcare providers can make informed decisions about the continuation, modification, or cessation of interferon-beta therapy for their patients.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the Interferon-Beta IgG MAID Test offers a critical tool for personalized patient care. The test is priced at 3630 AED, reflecting the sophisticated nature of the assay and the specialized expertise required to interpret its results. Through this testing, DNA Labs UAE supports clinicians in optimizing treatment strategies for patients with conditions like multiple sclerosis, enhancing the potential for positive outcomes.
The "Breast Cancer ER PR HER-2 Ki-67 Test" is a comprehensive diagnostic panel used in the evaluation and management of breast cancer. This test is conducted to assess the expression of four key biomarkers: Estrogen Receptor (ER), Progesterone Receptor (PR), Human Epidermal Growth Factor Receptor 2 (HER-2), and Ki-67. These biomarkers are crucial in determining the subtype of breast cancer, which in turn influences treatment decisions and prognosis.
1. **Estrogen Receptor (ER)** and **Progesterone Receptor (PR)** testing: These tests measure the presence of hormone receptors on cancer cells. Cancers that are hormone receptor-positive are more likely to respond to hormone therapy.
2. **HER-2**: This test evaluates the overexpression of the HER-2 protein on the surface of cancer cells, which is associated with a more aggressive form of breast cancer. HER-2 positive cancers may benefit from targeted therapies.
3. **Ki-67**: This marker is used to determine the proliferation rate of cancer cells, providing insight into how quickly the cancer is likely to grow and spread. A higher Ki-67 level indicates a more aggressive cancer.
The test is priced at 3600 AED and is available at DNA Labs UAE, a leading laboratory that specializes in genetic and molecular diagnostics. DNA Labs UAE provides advanced testing services with accurate and reliable results, employing state-of-the-art technology and adhering to international standards. This test is a critical tool in the personalized treatment planning for breast cancer patients, enabling healthcare providers to tailor therapies that are most likely to be effective for each individual's cancer subtype.
The Microsatellite Instability (MSI) PCR Test is a specialized diagnostic procedure used to detect the presence of microsatellite instability in DNA. This condition is characterized by changes in the length of microsatellites, which are short, repetitive sequences of DNA. MSI is a hallmark of certain types of cancers, including colorectal, endometrial, and gastric cancers, making this test a crucial tool in the identification and management of these diseases.
The test employs Polymerase Chain Reaction (PCR) technology to amplify microsatellite sequences from a patient's DNA sample, allowing for the detailed examination and comparison against normal sequences. By identifying discrepancies in these sequences, the test can indicate the presence of MSI, providing valuable information that can guide treatment decisions, including the suitability of certain chemotherapy drugs and the patient's prognosis.
At DNA Labs UAE, the MSI PCR Test is offered for 2800 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable results. This test is particularly important for patients with a family history of related cancers or those who have been diagnosed with conditions that predispose them to cancer, as it can play a significant role in early detection and personalized treatment planning.
The BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test is a specialized diagnostic procedure performed at DNA Labs UAE, aimed at detecting mutations within the kinase domain of the BCR-ABL1 gene. This gene is critically associated with chronic myeloid leukemia (CML) and some forms of acute lymphoblastic leukemia (ALL), where the presence of mutations can influence a patient's response to targeted therapies, particularly tyrosine kinase inhibitors (TKIs). The test is essential for guiding treatment decisions, monitoring resistance, and predicting outcomes for patients with these hematologic malignancies.
Utilizing cutting-edge technology, the IRMA (Isotope Ratio Mass Analysis) technique provides a highly sensitive and specific analysis of the BCR-ABL1 gene, ensuring accurate detection of mutations that could impact the efficacy of treatment. The cost of the test at DNA Labs UAE is 3200 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. This test is a crucial tool in the personalized management of leukemia, allowing for tailored treatment approaches that can significantly improve patient outcomes.
The "Beta Thalassemia-HBB Full Gene Analysis Couple Test" offered by DNA Labs UAE is a comprehensive genetic screening designed for couples who want to assess their risk of passing beta thalassemia to their offspring. Beta thalassemia is a blood disorder that reduces the production of hemoglobin, leading to anemia and various health complications. This condition is inherited in an autosomal recessive pattern, meaning both parents must carry the mutated gene to pass the disorder to their children.
The test involves analyzing the HBB gene, which is responsible for the production of the beta-globin component of hemoglobin. Mutations in this gene are the primary cause of beta thalassemia. By examining the full gene, the test can identify specific mutations that both partners carry, providing a comprehensive risk assessment for their potential children.
Priced at 3000 AED, the test is conducted in the advanced facilities of DNA Labs UAE, ensuring accuracy and reliability. The test results can help couples make informed decisions about family planning, and when a risk is identified, they can explore options such as genetic counseling or in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) to reduce the likelihood of having a child affected by beta thalassemia.
Overall, the "Beta Thalassemia-HBB Full Gene Analysis Couple Test" is a valuable resource for couples looking to understand their genetic risks and make informed decisions about their future family's health.
The "CAH Congenital Adrenal Hyperplasia Full Gene Sequence Analysis Test" is a comprehensive diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with Congenital Adrenal Hyperplasia (CAH). CAH is a group of inherited disorders affecting the adrenal glands, which are responsible for producing hormones that regulate various bodily functions. The test specifically sequences the genes known to be involved in CAH, allowing for an accurate diagnosis of the condition. This is particularly important for guiding treatment decisions and for genetic counseling. The test is priced at 3000 AED, reflecting the intricate technology and expertise required to perform the full gene sequencing and analysis. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step for individuals and families seeking insights into CAH, potentially leading to better management of the condition.
The "DMD Mutation Screening 79 Exons Prenatal Test" is a specialized genetic examination offered by DNA Labs UAE, designed to identify mutations within the 79 exons of the DMD gene, which is responsible for Duchenne Muscular Dystrophy (DMD). This condition is a severe form of muscular dystrophy that primarily affects boys, leading to progressive muscle degeneration and weakness. Early detection through prenatal testing can provide critical information for expecting parents on the health of their unborn child, allowing for informed decisions and preparation. The test is priced at 3000 AED and utilizes advanced genetic sequencing technologies to accurately screen for the presence of mutations in the DMD gene, ensuring high sensitivity and specificity. DNA Labs UAE, with its state-of-the-art facilities and expert geneticists, ensures a reliable and confidential testing process, making it a trusted choice for prenatal genetic screening.
